Management of myocardial infarction in a child with Kawasaki disease

##plugins.themes.academic_pro.article.sidebar##

Published Sep 18, 2018
Download
pdf
Vol. 96 No. 6 (2018): Issue Jun 2018

##plugins.themes.academic_pro.article.main##

Nejeh Ben Hlima
Yosra Messaoudi
Sameh Khammari
Hassine Metjaouel
Khaled Ben Hlel

Abstract

Although early treatment with intravenous immunoglobulin reduces the risk of cardiovascular complications in kawasakidisease , in refractory cases myocardial infarction can result from thrombosis of coronary artery aneurysms.This report describes successful management of myocardial infarction from coronary thrombosis in a 4 year old infant with kawasaki disease using intravenous Tenecteplase followed by percutaneous coronary intervention.

Keywords:

Kawasaki, myocardial infarction , Tenecteplase, Percutaneous treatment

##plugins.themes.academic_pro.article.details##

References

  1. Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger etal. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation December 5, 2017, Volume 136, Issue 23
  2. AlHuzaimi A, Al Mashham Y, Potts JE, De Souza AM, Sandor GG. Echo-Dopplerassessment of arterial stiffness in pediatric patients with Kawasaki disease. J Am Soc Echocardiogr 2013;26:1084-9
  3. Hashino K, Ishii M, Iemura M, Akagi T, Kato H: Re-treatment for immune globulinresistant Kawasaki disease: a comparative study of additional immune globulin andsteroid pulse therapy. PediatrInt 2001; 43: 211-7.
  4. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 2012;22:79-85)
  5. Kato H, Ichinose E, Kawasaki T: Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 1986; 108: 923-7.
  6. Tsubata S, Ichida Fl, Hamamichi Y, Miyazaki A, Hashimoto I, Okada T (1995) Successful thrombolytic therapy using tissuetype plasminogen activator in Kawasaki disease. Pediatr Cardiol 16:186-189
  7. Sohn S, Kwon K (2008) Accelerated thrombotic occlusion of a medium-sized coronary aneurysm in Kawasaki disease by the inhibitory effect of ibuprofen on aspirin. PediatrCardiol 29:153-156
  8. Matthew A. Crystal .Thrombolytic Use in Children: Breaking Down Barriers.The journal of pediatrics . April 2016Volume 171, Pages 12-13